Enovis to Participate in Upcoming Investor Conferences
18 nov. 2024 16h10 HE
|
Enovis Corporation
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Third Quarter 2024 Results
06 nov. 2024 06h00 HE
|
Enovis Corporation
Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9%...
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
10 oct. 2024 07h00 HE
|
Enovis Corporation
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
09 sept. 2024 15h50 HE
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
05 sept. 2024 08h00 HE
|
Enovis Corporation
Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus...
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
20 août 2024 08h00 HE
|
Enovis Corporation
WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to...
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
19 août 2024 08h00 HE
|
Enovis Corporation
Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, proudly unveils its Scandinavian Total Ankle Replacement (STAR®...
Enovis to Participate in Upcoming Investor Conferences
12 août 2024 16h10 HE
|
Enovis Corporation
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Second Quarter 2024 Results
07 août 2024 06h00 HE
|
Enovis Corporation
Continued strong momentum with second-quarter sales growth of 23% on a reported basis and strong adjusted margin expansionReported second-quarter net loss from continuing operations of $0.34 per share...
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
25 juil. 2024 06h00 HE
|
Enovis Corporation
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming...